AKT1 and cancer: Myricetin has been identified as having anti-cancer potential through modulation of a variety of cell signalling molecules and pathways, including inflammation, apoptosis, cell cycle, PI3K/Akt, angiogenesis, transcription factor/components, and also other compound or molecules (Figure 2).